Information Provided By: 
Fly News Breaks for September 28, 2015
VAR
Sep 28, 2015 | 05:24 EDT
Goldman Sachs analyst David Roman downgraded Varian Medical to Sell saying slowing growth puts Street estimates at risk. Oncology Systems capital growth has been stagnant for years with no turn in sight, Roman tells investors in a research note. He cut his price target for shares to $76 from $83.
News For VAR From the Last 2 Days
There are no results for your query VAR
